Lp(a)-cholesterol is associated with HDL-cholesterol in overweight and obese African American children and is not an independent risk factor for CVD by Sharma, Sushma et al.
ORIGINAL INVESTIGATION Open Access
Lp(a)-cholesterol is associated with HDL-
cholesterol in overweight and obese African
American children and is not an independent risk
factor for CVD
Sushma Sharma
1,2*, Jayshree Merchant
3 and Sharon E Fleming
1,2
Abstract
Background: The role of Lipoprotein (a) cholesterol {Lp(a)-C}as an additional and/or independent risk factor for
cardiovascular disease (CVD) is not clear. We evaluated the associations between Lp(a)-C and other CVD risk factors
including plasma lipoprotein concentrations and body fatness in overweight and obese African American children.
Methods: A cross-sectional analysis was carried out using data from a sample of 121 African American children
aged 9-11 years with Body Mass Index (BMI)’s greater than the 85th percentile. Body height, weight and waist
circumference (WC) were measured. Fasting plasma concentrations of Lp(a)-C, Total cholesterol (TC), High density
lipoprotein cholesterol (HDL-C), Very low density lipoprotein cholesterol (VLDL-C), Intermediate density lipoprotein
cholesterol (IDL-C), Low density lipoprotein cholesterol (LDL-C), and Triacylglycerides (TAG) were analyzed using the
vertical auto profile (VAP) cholesterol method.
Results: After adjusting for child age, gender, and pubertal status, Lp(a)-C was positively associated with both HDL-
C and TC, and negatively associated with VLDL-C and TAG. Including BMIz and WC as additional covariates did not
alter the direction of the relationships between Lp(a)-C and the other lipoproteins. Finally, after adjusting for the
other plasma lipoproteins, Lp(a)-C remained strongly associated with HDL-C, whereas the associations of Lp(a)-C
with the other lipoproteins were not significant when HDL-C was simultaneously included in the regression
models.
Conclusions: Lp(a)-C was positively associated with HDL-C and this association is not influenced by other
lipoprotein subclasses or by the degree of obesity. We conclude that Lp(a) cholesterol is not an independent risk
factor for CVD in African American children.
Keywords: Lipoprotein, Lp(a), LDL, HDL, TAG, TC, BMIz, Waist circumference, Obesity, CVD, Atherosclerosis
Background
Lipoprotein (a) particles, Lp(a), were first described by
Berg in 1963 [1], and are a genetic variant of low-den-
sity lipoprotein particles linked via apoB-100 to apolipo-
protein(a) [2]. Since being identified, numerous studies
have reported that high plasma Lp(a) concentrations are
associated with atherosclerotic/thrombotic disease, as
comprehensively reviewed by others [3].
Despite these reports, there have been conflicting
results from prospective studies that evaluated Lp(a) as
an independent risk factor for cardiovascular disease
(CVD). Although the majority of studies, performed in
primarily Caucasian populations, have found Lp(a) con-
centrations to be an independent risk factor for CVD,
studies that have evaluated these relationships in African
Americans have been less consistent. For example, in
the biracial cohort ARIC (Atherosclerosis Risk in Com-
munities) study of 15, 800 individuals, Lp(a) lipoprotein
levels were reported to be positively associated with
CVD as well as with preclinical atherosclerosis in both
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medium, provided the original work is properly cited.Black and White adults [4,5]. In a different study, how-
ever, high Lp(a) concentrations were reported not to be
associated with increased risk of CVD in African Ameri-
cans adults [6]. When compared to other races and eth-
nicities, African American adults and children have been
shown to have higher plasma concentrations of Lp(a).
These, among other findings, have led researchers to
conclude that Lp(a) levels are regulated by both genetic
and non-genetic factors [7], suggesting that a single Lp
(a) cutoff would not confer the same CVD risk in Afri-
can American and White populations [8].
In the U.S., plasma lipoprotein concentrations and
blood pressures have been used as predictors for CVD
screening, with cutoffs based on American Heart Asso-
ciation guidelines [9]. Individuals with higher than
recommended concentrations of Total Cholesterol (TC),
Low density lipoprotein cholesterol (LDL-C), Very low
density lipoprotein cholesterol (VLDL-C), Intermediate
density lipoprotein cholesterol (IDL-C) or Triglycerides
(TAG), and lower High density lipoprotein cholesterol
(HDL-C) would be considered at risk of CVD. To deter-
mine whether Lp(a) confers additional and independent
risk, several studies have investigated the relationship of
Lp(a) to these intermediate markers of CVD risk. Lp(a)
has been reported to be positively associated with TC in
Turkish adults [10] and high-school adolescents [11];
and Lp(a) and LDL-C have been reported to be posi-
tively associated in White adults [12,13], Australian
Aboriginal children [14] and Taiwanese boys [15].
Lp(a) has been found also to be associated with inter-
mediate markers of CVD risk including obesity and
other lipoproteins in African Americans. Lp(a) was
reported to be positively associated with TC in African
American women [16] and African American 12-19 year
old males [17]. Also, Lp(a) and LDL-C have been
reported to be positively associated in African American
men [13] and women [13,16]. Some unexpected associa-
tions have been reported. For example, Giger et al. [16]
reported that Lp(a) was positively associated with HDL-
C and negatively associated with TAG, VLDL-C and
obesity in premenopausal African American women;
and Randall et al [17] reported a negative association
between Lp(a) and TAG in obese American Americans
aged 12-75 years.
To the best of our knowledge, associations between Lp
(a) and intermediate markers of CVD risk have not pre-
viously been reported for young African American chil-
dren. Because of an epidemic increase in childhood
obesity and a subsequent increase in risk for CVD, it
has been recommended that children and adolescents
should be screened for lipid profiles even at a young age
[18,19]. Therefore, knowledge regarding the association
between Lp(a)-C and markers of CVD risk in overweight
and obese African American children would provide
crucial information regarding choice of markers for
CVD risk determination in at risk children, and others
have determined that it is essential to evaluate pediatric
cohorts individually due to heterogeneity [20]. The cur-
rent study represents a secondary analysis of data gener-
ated from a community-based, type 2 diabetes
prevention program for inner city, overweight and
obese, African American children [21]. In this analysis,
we aimed to evaluate the associations of Lp(a)-C with
other cardiovascular disease risk factors including lipo-
proteins (TC, HDL-C, LDL-C, VLDL-C, TAG) and body
fatness (BMIz and waist circumference) in this sample
of overweight and obese, young African American
children.
Methods
Study participants
A complete set of data for this cross-sectional analysis
were available for a convenience sample of 121 (56 boys
and 65 girls) African-American children who were part
of a community-based lifestyle modification program
that aimed to reduce the risk for type 2 diabetes melli-
tus as described more fully elsewhere [21]. Study partici-
pants were recruited by distributing pamphlets at local
recreational sites and schools in inner-city Oakland, CA.
Recruitment targeted children with at least one African
American parent. Exclusion criteria included the follow-
ing: BMI’s below the 85th percentile when matched for
age and gender; 8 years of age or younger; 12 years of
age or older; fasting glucose ≥ 120 mg/dl; any known
metabolic disease; or taking medications known to affect
the study outcomes. Parental informed consent was
obtained from all subjects, and all protocols were
approved by the institutional review boards at the Uni-
versity of California Berkeley and San Francisco. More
than 95% of the children enrolled in this study lived in
inner-city Oakland, CA.
Anthropometric measurements
Body weight and height were measured to the nearest
0.1 kg and 0.1 cm using a digital electronic scale (BWB
800, Tanita, Japan), and a portable stadiometer, respec-
tively. Body mass index (BMI), BMI percentiles and BMI
z-scores were generated using an age and gender speci-
fic CDC calculator program http://www.cdc.gov/
nccdphp/dnpa/growthcharts/resources/sas.htm. Using a
plastic, non-elastic measuring tape, waist circumference
(WC) was measured just above the iliac crest with the
child in the standing position and hip circumference
was measured at the widest point above the greater tro-
canthers. Measurements were taken twice and if agree-
ment between repeats exceeded 0.4 cm, a third
measurement was taken and the mean calculated using
the closest two values.
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After a 12-h overnight fast, participants reported to the
Children’s Hospital and Research Center Oakland where
their blood was drawn. Plasma lipids were measured by
a comprehensive lipoproteina n a l y s i sp e r f o r m e db ya
commercial lab (LabCorp). Using the vertical auto pro-
file (VAP) cholesterol method, a modified density gradi-
ent centrifugation technique, concentrations of the
following components were determined on a single sam-
ple: TC, HDL-C, VLDL-C, IDL-C, LDL-C and TAG
[22,23].
Pubertal stage assessment
All participants were asked to report, after an overnight
fast of at least 12 h, at the Children’sH o s p i t a la n d
Research Center in Oakland, CA for blood sample col-
lection. Pubertal development was assessed by measure-
ments of serum luteinizing hormones (LH) in boys, and
estradiol and LH in girls. Children were classified into
stages 1 through 5 using literature-derived values and
with cutoffs previously reported [24].
Statistical analyses
Initially, data for 124 participants were included in the
analysis. Values for several of the plasma lipoproteins
were significantly skewed, and tests for non-normality
remained significant even following log transformation.
Using Dixon’s test for outliers, data for three children
were excluded to avoid unintended bias of associations
in this analysis. Thus, data for 121 participants were
included in the final analysis. Gender differences for
anthropometric and lipoprotein characteristics were
assessed using independent two-tailed t-tests following
Levene’s test for equality of variances. Pearson’s correla-
tions were used to determine bivariate associations. To
evaluate the primary study objectives, hierarchical multi-
ple linear regression analyses were used, with Lp(a)-C as
the dependent variable. Other plasma lipoproteins were
included as independent variables and models were
adjusted as indicated for child age, gender, pubertal
stage and body fatness. Socioeconomic status of the
family was evaluated as a potential covariate but was
not included in the final models since it was found to
have r < 0.20 and to not be significantly related to
dependent and independent variables. Statistical proce-
dures were performed using SPSS for Windows version
18.0 PASW (SPSS, IBM Corp.). Results with p <0 . 0 5
were defined to be statistically significant.
Results
Plasma lipoprotein concentrations were considered to be
in the normal range for many, but not all, of the children
in this sample. Using reference interval cutoffs, less than
5% of the children had values outside the normal range
for IDL-C, VLDL-C and TAG; 10-20% fell outside the
normal range for TC, HDL-C and LDL-C; and nearly
25% fell outside the normal range for Lp(a)-C (Table 1).
Girls in this sample of overweight and obese African
American children were at a more advance pubertal
stage than boys, and had significantly higher body fatness
assessed by BMIz and WC values (Table 2). Differences
in lipoprotein concentrations did not differ by gender.
When participants were divided into three BMI
Table 1 Standardized reference cutoffs for plasma
lipoprotein concentrations and proportion of child
participants at risk of cardiovascular disease (n = 121)
Reference Cutoff
1, mg/dl At risk,% of sample
TC > 200 17.4
HDL-C ≤ 40 12.4
VLDL-C > 30 1.7
IDL-C > 20 3.3
LDL-C > 130 14.0
TAG > 150 1.7
Lp(a)-C > 10 24.8
1Reference cutoff intervals taken from LabCorp standards for VAP Cholesterol
analyses https://www.labcorp.com/pdf/VAP_test_flyer.pdf
Abbreviations: Total cholesterol: TC, High density lipoprotein cholesterol: HDL-
C, Very low density lipoprotein cholesterol: VLDL-C, Intermediate density
lipoprotein cholesterol: IDL-C, Low density lipoprotein cholesterol: LDL-C,
Triglycerides: TAG, Lp(a) cholesterol: Lp(a)-C
Table 2 Characteristics of participating African-American
boys and girls
Boys Girls p-value
1
Sample size, n 56 65
Anthropometrics Mean (SEM)
Age (years) 10.7 (0.1) 10.6 (0.1) 0.575
Pubertal stage 2.4 (0.2) 3.5 (0.1) < 0.001
Height (cm) 148.1 (0.02) 150.8 (0.01) 0.248
Weight (kg) 62.5 (2.6) 69.1 (2.3) 0.057
BMI-z score 2.0 (0.07) 2.2 (0.05) 0.050
WC (cm) 87.0 (2.1) 93.0 (1.8) 0.032
Plasma lipoproteins, mg/dl
TC 168.0 (3.6) 168.3 (4.6) 0.955
HDL-C 56.2 (1.6) 52.0 (1.4) 0.052
VLDL-C 15.9 (0.6) 16.1 (0.4) 0.736
IDL-C 9.1 (0.6) 9.4 (0.6) 0.724
LDL-C 95.9 (3.2) 100.4 (4.0) 0.371
TAG 68.4 (4.4) 75.1 (3.1) 0.202
Lp(a)-C 7.8 (0.54) 8.1(0.51) 0.699
1Statistical significance of differences determined using two-tailed t-test
following Levene’s test for equality of variances
Abbreviations: Body mass index: BMI, Body mass index z-score: BMIz, Waist
circumference: WC, Total cholesterol: TC, High density lipoprotein cholesterol:
HDL-C, Very low density lipoprotein cholesterol: VLDL-C, Intermediate density
lipoprotein cholesterol: IDL-C, Low density lipoprotein cholesterol: LDL-C,
Triglycerides: TAG, Lp(a) cholesterol: Lp(a)-C
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ences among subgroups were statistically significant for
concentrations of HDL-C, Lp(a)-C and TAG (Table 3).
Body fatness, assessed using either BMIz scores and
WC, was significantly and negatively correlated with
HDL-C and Lp(a)-C, and significantly but positively
associated with TAG (Table 4). TC was positively asso-
ciated with all concentrations of all lipoprotein sub-
classes and, among the subclasses, HDL-C was
negatively associated with VLDL-C and TAG; and
VLDL-C, IDL-C and LDL-C were intercorrelated. Lp(a)-
C was positively correlated with TC and HDL-C, and
negatively correlated with VLDL-C and TAG.
Using multiple regression analysis, and following adjust-
ments for child age, gender and pubertal stage, Lp(a)-C
remained significantly and positively associated with TC
and HDL-C, and remained significantly and negatively asso-
ciated with VLDL-C and TAG (Table 5). Since obesity was
highly correlated with Lp(a)-C, we included WC and BMIz
(separately) as additional covariates. Associations of Lp(a)-C
with TC, HDL-C, VLDL-C and TAG continued to be statis-
tically significant after these adjustments for body fatness.
Table 3 Influence of BMI percentile category on characteristics of participating children
Classification BMI percentiles At risk of overweight 85-95th Overweight & Obese
95.001-99 th > 99 th p-value
1
Sample size, n 24 48 49
Anthropometrics Mean (SEM)
Age (years) 10.5 (0.2) 10.8 (0.1) 10.7 (0.1) 0.412
Pubertal stage 2.75 (0.3) 3.14(0.2) 2.95 (0.2) 0.574
Height (cm) 147.3 (1.8) 150.2 (1.3) 152.1 (1.3) 0.118
Weight (kg) 46.6 (1.5) 61.0 (1.4) 80.5 (2.6) < 0.001
BMI-z score 1.34 (0.4) 2.03 (0.03) 2.54 (0.02) < 0.001
WC (cm) 71.8 (1.4) 86.9 (1.19) 102.4 (1.8) < 0.001
Plasma lipoproteins, mg/dl
TC 177.7 (7.0) 161.1 (4.1) 170.5 (4.9) 0.100
HDL-C 62.2
b (2.8) 53.0
a (1.4) 50.8
a (1.5) < 0.001
VLDL-C 15.6 (0.9) 15.2 (0.5) 16.9 (0.5) 0.099
IDL-C 9.38 (1.0) 8.33 (0.6) 10.1 (0.6) 0.172
LDL-C 100.1 (6.2) 92.9 (3.6) 102.7 (4.3) 0.227
TAG 59.5
a (4.5) 68.5
a, b (3.8) 81.5
b (4.5) 0.005
Lp(a)-C 10.7
b (0.9) 7.75
a (0.5) 6.71
a (0.5) < 0.001
1Differences determined using two-tailed t-test following Levene’s test for equality of variances. Groups sharing a common superscript are not significantly
different from each other using Tukey’s studentized range test at a 5% procedure-wise error rate
Abbreviations: Body mass index: BMI, Body mass index z-score: BMIz, Waist circumference: WC, Total cholesterol: TC, High density lipoprotein cholesterol: HDL-C,
Very low density lipoprotein cholesterol: VLDL-C, Intermediate density lipoprotein cholesterol: IDL-C, Low density lipoprotein cholesterol: LDL-C, Triglycerides: TAG,
Lp(a)ccholesterol: Lp(a)-C
Table 4 Pearson correlation coefficients and significance
1 among measure of obesity and plasma lipoprotein
concentrations (n = 121)
WC TC HDL-C VLDL-C IDL-C LDL-C TAG Lp(a)-C
BMIz 0.801*** -0.019 -0.348*** 0.212* 0.134 0.090 0.357*** -0.394***
WC -0.107 -0.476*** 0.187* 0.104 0.050 0.332*** -0.337***
TC 0.384*** 0.310*** 0.562*** 0.934*** 0.228* 0.219*
HDL-C -0.224* -0.117 0.051 -0.285** 0.462***
VLDL-C 0.803*** 0.306*** 0.869*** -0.254**
IDL-C 0.574*** 0.699*** -0.155
LDL-C 0.258** 0.097
TAG -0.283**
1Significance: * for p < 0.05, ** for p < 0.01, *** for p < 0.001
Abbreviations: Body mass index: BMI, Body mass index z-score: BMIz, Waist circumference: WC, Total cholesterol: TC, High density lipoprotein cholesterol: HDL-C,
Very low density lipoprotein cholesterol: VLDL-C, Intermediate density lipoprotein cholesterol: IDL-C, Low density lipoprotein cholesterol: LDL-C, Triglycerides: TAG,
Lp(a) cholesterol: Lp(a)-C
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strongly related to HDL-C than to the other lipoprotein
subclasses (Table 5), a final analysis was performed to
determine if the association between Lp(a)-C and HDL-
C was accounted for by other plasma lipoproteins since
inter-correlations were observed among the lipoprotein
subclasses (Table 5). The strong relationship between
HDL-C and Lp(a)-C was not explained by its association
with other lipoprotein subclasses since, after adjusting
for each subclass in a separate regression model, Lp(a)-
C remained highly related to HDL-C whereas associa-
tions of Lp(a)-C with other lipoprotein subclasses were
no longer statistically significant (Table 6).
Finally, we evaluated the frequency with which chil-
dren in our cohort were simultaneously “at risk” of
CVD using the cutoffs provided in Table 1. None of the
children in the “at risk” categories using cutoffs for
HDL-C, VLDL-C, IDL-C or TAG were in the “at risk”
category for Lp(a) (data not shown). Of the children in
the “at risk” categories using the cutoffs for TC or LDL-
C, only 1/3 were in the “at risk” category for Lp(a).
Discussion
To our knowledge this is one of the first studies to
report a strong positive association between Lp(a)-C and
HDL-C in overweight and obese African American chil-
dren. Positive correlations between Lp(a)-C and HDL-C
concentrations have been reported previously in preme-
nopausal African American women [16], and our results
show that this relationship can be observed prior to
adulthood. Although, others have reported no associa-
tion between Lp(a)-C and HDL-C in normal weight girls
[25], our results expand on the current literature by
showing that the strong positive association between Lp
(a)-C and HDL-C in overweight and obese African
American children included in our study. This associa-
tion remained following adjustments for body fatness
and following adjustments for other plasma lipoprotein
subclasses.
The strong association of Lp(a)-C with HDL-C
observed in our study suggests that increasing Lp(a)-C
concentrations may not be reliably used as a marker of
CAD risk in this population. Instead, our results agree
Table 5 Relationship of other plasma lipoproteins to Lp(a)-C concentrations (n = 121)
Independent variables
1
Models Other variables included in models TC HDL-C VLDL-C IDL-C LDL-C TAG
Standardized regression coefficient with Lp(a) as dependent variable
2
I None 0.219* 0.462*** -0.254** -0.155 0.097 -0.283**
II Covar 0.244** 0.541*** -0.276** -0.166 0.114 -0.307***
III Covar + BMIz 0.235** 0.446*** -0.196* -0.113 0.145 -0.187*
IV Covar + WC 0.227** 0.450*** -0.200* -0.108 0.142 -0.190*
1Regression analyses were performed separately for each independent lipoprotein variable. Coefficients are shown following adjustments for covariates (covar)
including child sex, age, pubertal stage, group assignment and family socio-economic status
2Significance: * for p < 0.05, ** for p < 0.01, *** for p ≤ 0.001
Abbreviations: Body mass index: BMI, Body mass index z-score: BMIz, Waist circumference: WC, Total cholesterol: TC, High density lipoprotein cholesterol: HDL-C,
Very low density lipoprotein cholesterol: VLDL-C, Intermediate density lipoprotein cholesterol: IDL-C, Low density lipoprotein cholesterol: LDL-C, Triglycerides: TAG,
Lp(a) cholesterol: Lp(a)-C
Table 6 Relationship of plasma concentrations of Lp(a)-C to HDL-C before and after adjustments for other plasma
lipoproteins (n = 121)
Independent variables
Models
1 HDL-C TC VLDL-C IDL-C LDL-C TAG
Standardized regression coefficients with Lp(a) as dependent variable
2
IV 0.450***
V 0.411*** 0.093
VI 0.424*** -0.135
VII 0.442*** -0.070
VIII 0.440*** 0.114
IX 0.428*** -0.121
1Regression analyses were performed for models that included the covariates (child age, gender, pubertal stage and waist circumference), and with HDL-C
entered alone (model IV) or with one of the other independent lipoprotein variables of interest (models V-IX)
2Significance: *** for p ≤ 0.001
Abbreviations: Total cholesterol: TC, High density lipoprotein cholesterol: HDL-C, Very low density lipoprotein cholesterol: VLDL-C, Intermediate density lipoprotein
cholesterol: IDL-C, Low density lipoprotein cholesterol: LDL-C, Triglycerides: TAG, Lp(a) cholesterol: Lp(a)-C
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tic lifestyle modification program administered to obese
African Americans aged 12-75 years caused levels of Lp
(a) and HDL-C to increase and caused LDL-C, TC, TG
and BMI to decrease. Those authors reasoned that,
since previous studies with therapeutic life style change
have shown a favorable impact on cardio vascular
health, their results, like ours, did not support the estab-
lished understanding that elevations in Lp(a) would be
atherogenic and harmful. Thus, our results in over-
weight and obese African American children are in line
with the suggestion, made by others [6], that increasing
plasma concentration of Lp(a) is not an independent
risk factor for CVD in African American adults.
Lp(a) is known to consist of an LDL-like particle cova-
lently linked via an apo-B100 molecule to apolipoprotein
(a), and these particles are variable in its size and cho-
lesterol content. Lp(a) and LDL have been reported to
be positively correlated in African American females
[16,25] and in Taiwanese boys [15] and white girls [11].
Relationships were reported not to be significant, how-
ever, in Taiwanese girls [15], white boys, black boys and
black girls [11]. In our population, Lp(a)-C and LDL-C
concentrations also were not found to be significantly
associated even after adjusting for child characteristics
including degree of obesity. This lack of association is
unlikely to be due to the analytical procedure used since
Lp(a)-C, measured using the VAP-C technique as we
have done, has been reported to be highly correlated to
Lp(a) mass measured using ELISA [23].
In our cohort of overweight African American chil-
dren, Lp(a) was significantly and negatively associated
with TAG concentrations prior to an following adjust-
ment for obesity. Others have reported also a negative
association between LP(a) and TAG in American Amer-
icans aged 12-75 [17], African American women [16],
Turkish men and women [10], and Taiwanese girls [15].
Although our results agree with those of others, the
association was no longer significant following adjust-
m e n tf o rH D L - C .T h i ss u g g e s t st h a tH D L - Ca c c o u n t s
for the association between Lp(a) and TAG observed by
us and others.
Others have previously reported that African Ameri-
can children and adolescents have higher levels of Lp(a)
and HDL than their non-Hispanic white peers
[11,25,26]. In our cohort, nearly 25% of children had Lp
(a)-C concentrations that placed them in the “at risk”
category whereas only 12% had HDL-C concentrations
that placed them in the “at risk” category. Of interest, is
our observation that, of the 15 individual children in
our cohort with low “at risk” HDL-C, none had “at risk”
Lp(a)-C concentrations. Thus, the strong positive asso-
ciation we observed between Lp(a)-C and HDL-C sug-
gests it is unlikely that both of these factors would serve
as a reliable marker for risk of CVD in overweight and
obese African American children.
In our population, Lp(a)-C concentrations were nega-
tively related to body fatness assessed using either BMIz
or WC, and children between the 85th and 95th BMI
percentile had significantly higher Lp(a)-C concentra-
tions than children with BMIs above the 95th percentile.
Previously, Lp(a)-C concentrations were reported to be
negatively correlated with body weight and waist-to-hip
ratio in African American women [16], although no
association was found between Lp(a) levels and obesity
in non-African American children or adults [15,27].
Because Lp(a)-C was correlated with obesity in our
population, BMIz or WC were included as covariates in
our multiple regression models. Our results show, how-
ever, that the positive association between Lp(a)-C and
HDL-C was independent of the degree of obesity in
these children.
This pilot analysis includes restriction to low-income,
inner-city, African American children and exclusion of
children with BMI’s less than the 85th percentile when
matched for age and gender. These limitations preclude
extrapolation to the wider population of children of dif-
ferent races, ages and socioeconomic backgrounds, and
comparisons with lower BMI children. This is a cross-
sectional analysis of data, precluding a cause and effect
relationship. Lipoprotein subclasses were analyzed using
the VAP-cholesterol technique, precluding extrapolation
to results based on other analytical techniques that
quantify numbers or size of particles or associated
protein.
Conclusions
Lp(a)-C was positively associated with HDL-C in over-
weight and obese African American children and this
association remained following adjustments for other
lipoprotein subclasses and degree of obesity. Based on
our study, we propose that Lp(a) is not associated with
lipoprotein recognized as markers of increased risk of
CVD in overweight and obese African American chil-
dren. Further studies will be needed to explain the basis
for the association of Lp(a)-C and HDL-C in these
children.
Abbreviations
Lp(a): Lipoprotein (a); Lp(a)-C: Lp(a) cholesterol; LDL-C: Low density
lipoprotein cholesterol; HDL-C: High density lipoprotein cholesterol; IDL-C:
Intermediate density lipoprotein cholesterol; VLDL-C: Very low density
lipoprotein cholesterol;TAG: Triglycerides; TC: Total cholesterol; BMI: Body
mass index; BMIz: Body mass index z-score; WC: Waist circumference; CVD:
Cardiovascular disease.
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